Correlation of volumetric growth and histological grade in 50 meningiomas

  • Wai Cheong Soon
  • Daniel M. Fountain
  • Kacper Koczyk
  • Mutwakil Abdulla
  • Sachin Giri
  • Kieren Allinson
  • Tomasz Matys
  • Mathew R. Guilfoyle
  • Ramez W. Kirollos
  • Thomas Santarius
Original Article - Functional



Advances in radiological imaging techniques have enabled volumetric measurements of meningiomas to be easily monitored using serial imaging scans. There is limited literature on the relationship between tumour growth rates and the WHO classification of meningiomas despite tumour growth being a major determinant of type and timing of intervention. Volumetric growth has been successfully used to assess growth of low-grade glioma; however, there is limited information on the volumetric growth rate (VGR) of meningiomas. This study aimed to determine the reliability of VGR measurement in patients with meningioma, assess the relationship between VGR and 2016 WHO grading as well as clinical applicability of VGR in monitoring meningioma growth.


All histologically proven intracranial meningiomas that underwent resection in a single centre between April 2009 and April 2014 were reviewed and classified according to the 2016 edition of the Classification of the Tumours of the CNS. Only patients who had two pre-operative scans that were at least 3 months apart were included in the study. Two authors performed the volumetric measurements using the Slicer 3D software independently and the inter-rater reliability was assessed. Multiple regression analyses of factors affecting the VGR and VDE of meningiomas were performed using the R statistical software with p < 0.05 considered to be statistically significant.


Of 548 patients who underwent resection of their meningiomas, 66 met the inclusion criteria. Sixteen cases met the exclusion criteria (NF2, spinal location, previous surgical or radiation treatment, significant intra-osseous component and poor quality imaging). Forty-two grade I and 8 grade II meningiomas were included in the analysis. The VGR was significantly higher for grade II meningiomas. Using receiver-operator characteristic (ROC) curve analysis, the optimal threshold that distinguishes between grade I and II meningiomas is 3 cm3/year. Higher histological grade, high initial tumour volume, MRI T2-signal hyperintensity and presence of oedema were found to be significant predictors of higher VGR.


Reliable tools now exist to evaluate and monitor volumetric growth of meningiomas. Grade II meningiomas have significantly higher VGR compared with grade I meningiomas and growth of more than 3 cm3/year is strongly suggestive of a higher grade meningioma. A larger, multi-centre prospective study to investigate the applicability of velocity of growth to predict the outcome of patients with meningioma is warranted.


Meningioma Volumetry Growth Histology 


  1. 1.
    Backer-Grøndahl T, Moen BH, Torp SH (2012) The histopathological spectrum of human meningiomas. Int J Clin Exp Pathol 5(3):231–242PubMedPubMedCentralGoogle Scholar
  2. 2.
    Scheithauer BW (2009) Development of the WHO classification of tumors of the central nervous system: a historical perspective. Brain Pathol Zurich Switz 19(4):551–564CrossRefGoogle Scholar
  3. 3.
    D’Ambrosio AL, Bruce JN (2003) Treatment of meningioma: an update. Curr Neurol Neurosci Rep 3(3):206–214CrossRefPubMedGoogle Scholar
  4. 4.
    Pallud J, Taillandier L, Capelle L, Fontaine D, Peyre M, Ducray F, Duffau H, Mandonnet E (2012) Quantitative morphological magnetic resonance imaging follow-up of low-grade glioma: a plea for systematic measurement of growth rates. Neurosurgery 71(3):729–739CrossRefPubMedGoogle Scholar
  5. 5.
    Fountain DM, Soon WC, Matys T, Guilfoyle MR, Kirollos R, Santarius T (2017) Volumetric growth rates of meningioma and its correlation with histological diagnosis and clinical outcome: a systematic review. Acta Neurochir 159(3):435–445CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Data and Statistical Services - Interpreting Regression Output [Internet]. (2016) Available from: [last accessed 15 December 2016]
  7. 7.
    Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2016) World Health Organization histological classification of tumours of the central nervous system, vol 1, 4th Edition Revised edn. International Agency for Research on Cancer, WHO Press, Geneva, pp 231–244Google Scholar
  8. 8.
    Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820CrossRefPubMedGoogle Scholar
  9. 9.
    Egger J, Kapur T, Fedorov A, Pieper S, Miller JV, Veeraraghavan H, Freisleben B, Golby AJ, Nimsky C, Kikinis R (2013) GBM volumetry using the 3D Slicer medical image computing platform. Sci Rep 3:1364CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Nakamura M, Roser F, Michel J, Jacobs C, Samii M (2005) Volumetric analysis of the growth rate of incompletely resected intracranial meningiomas. Zentralblatt Für Neurochir 66(1):17–23CrossRefGoogle Scholar
  11. 11.
    Core Team R (2014) R: a language and environment for statistical computing R foundation for statistical computing. R Foundation for Statistical Computing, Vienna (Austria) Available from: [last accessed 20 January 2017]Google Scholar
  12. 12.
    Jääskeläinen J, Haltia M, Laasonen E, Wahlström T, Valtonen S (1985) The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients. Surg Neurol 24(2):165–172CrossRefPubMedGoogle Scholar
  13. 13.
    Maillo A, Orfao A, Espinosa AB, Sayagués JM, Merino M, Sousa P, Lara M, Tabernero MD (2007) Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone. Neuro-Oncology 9(4):438–446CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin-Hanjani S, Martuza RL, Curry WT Jr, Barker FG 2nd (2009) Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64(1):56–60CrossRefPubMedGoogle Scholar
  15. 15.
    Ho DM, Hsu CY, Ting LT, Chiang H (2002) Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Cancer 94(5):1538–1547CrossRefPubMedGoogle Scholar
  16. 16.
    Ide M, Jimbo M, Yamamoto M, Umebara Y, Hagiwara S, Kubo O (1996) MIB-1 staining index and peritumoral brain edema of meningiomas. Cancer 78(1):133–143CrossRefPubMedGoogle Scholar
  17. 17.
    Maier H, Wanschitz J, Sedivy R, Rössler K, Öfner D, Budka H (1997) Proliferation and DNA fragmentation in meningioma subtypes. Neuropathol Appl Neurobiol 23(6):496–506CrossRefPubMedGoogle Scholar
  18. 18.
    Hashimoto N, Rabo CS, Okita Y, Kinoshita M, Kagawa N, Fujimoto Y, Morii E, Kishima H, Maruno M, Kato A, Yoshimine T (2012) Slower growth of skull base meningiomas compared with non-skull base meningiomas based on volumetric and biological studies. J Neurosurg 116(3):574–580CrossRefPubMedGoogle Scholar
  19. 19.
    Nakaguchi H, Fujimaki T, Matsuno A, Matsuura R, Asai A, Suzuki I, Sasaki T, Kirino T (1999) Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry. Cancer 85(10):2249–2254CrossRefPubMedGoogle Scholar
  20. 20.
    Simis A, Pires de Aguiar PH, Leite CC, Santana PA Jr, Rosemberg S, Teixeira MJ (2008) Peritumoral brain edema in benign meningiomas: correlation with clinical, radiologic, and surgical factors and possible role on recurrence. Surg Neurol 70(5):471–477CrossRefPubMedGoogle Scholar
  21. 21.
    Hunter JB, Yawn RJ, Wang R, O'Connell BP, Carlson ML, Mistry A, Haynes DS, Thompson RC, Weaver KD, Wanna GB (2017) The natural history of petroclival meningiomas: a volumetric study. Otol Neurotol 38(1):123–128CrossRefPubMedGoogle Scholar
  22. 22.
    Oya S, Kim S-H, Sade B, Lee JH (2011) The natural history of intracranial meningiomas. J Neurosurg 114(5):1250–1256CrossRefPubMedGoogle Scholar
  23. 23.
    Zeng L, Liang P, Jiao J, Chen J, Lei T (2015) Will an asymptomatic meningioma grow or not grow? A meta-analysis. J Neurol Surg A Cent Eur Neurosurg 76(5):341–347CrossRefPubMedGoogle Scholar
  24. 24.
    Nakamura M, Roser F, Michel J, Jacobs C, Samii M (2003) The natural history of incidental meningiomas. Neurosurgery 53(1):62–70CrossRefPubMedGoogle Scholar
  25. 25.
    Chen TC, Zee CS, Miller CA, Weiss MH, Tang G, Chin L, Levy ML, Apuzzo ML (1992) Magnetic resonance imaging and pathological correlates of meningiomas. Neurosurgery 31(6):1015–1021CrossRefPubMedGoogle Scholar
  26. 26.
    Zee CS, Chin T, Segall HD, Destian S, Ahmadi J (1992) Magnetic resonance imaging of meningiomas. Semin Ultrasound CT MR 13(3):154–169PubMedGoogle Scholar
  27. 27.
    TennerMS SM, Koenig SH, Valsamis MP, Childress S, Brown RD 3rd, Kasoff SS (1995) Calcification can shorten T2, but not T1, at magnetic resonance imaging fields. Results of a relaxometry study of calcified human meningiomas. Investig Radiol 30(6):345–353CrossRefGoogle Scholar
  28. 28.
    Sughrue ME, Rutkowski MJ, Shangari G, Chang HQ, Parsa AT, Berger MS, McDermott MW (2011) Risk factors for the development of serious medical complications after resection of meningiomas. J Neurosurg 114(3):697–704CrossRefPubMedGoogle Scholar
  29. 29.
    Chamoun R, Krisht KM, Couldwell WT (2011) Incidental meningiomas. Neurosurg Focus 31(6):E19CrossRefPubMedGoogle Scholar
  30. 30.
    Yano S, Kuratsu J (2006) Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience. J Neurosurg 105(4):538–543CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria 2017

Authors and Affiliations

  • Wai Cheong Soon
    • 1
    • 2
    • 3
  • Daniel M. Fountain
    • 1
  • Kacper Koczyk
    • 1
    • 4
  • Mutwakil Abdulla
    • 1
  • Sachin Giri
    • 1
    • 5
  • Kieren Allinson
    • 6
  • Tomasz Matys
    • 7
  • Mathew R. Guilfoyle
    • 1
  • Ramez W. Kirollos
    • 1
  • Thomas Santarius
    • 1
  1. 1.Department of NeurosurgeryCambridge University Hospitals NHS Foundation Trust, University of CambridgeCambridgeUK
  2. 2.Edinburgh Surgical Sciences QualificationUniversity of EdinburghEdinburghUK
  3. 3.Department of NeurosurgeryRoyal Stoke University HospitalStoke-on-TrentUK
  4. 4.Medical University of WarsawWarsawPoland
  5. 5.Department of NeurosurgeryGrant Government Medical College HospitalMumbaiIndia
  6. 6.Department of PathologyCambridge University Hospitals NHS Foundation TrustCambridgeUK
  7. 7.Department of RadiologyUniversity of CambridgeCambridgeUK

Personalised recommendations